Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02626702 · ClinicalTrials.gov registry record

Immune Modulators and IVF

A clinical trial, sponsored by Weill Medical College of Cornell University.

Terminated
Registry status
500
Enrollment target

NCT02626702 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02626702 was terminated before completion, sponsored by Weill Medical College of Cornell University.

TERMINATED
Registry status
500 participants
Enrollment target

Study Summary

Exploring the immune mediators of early pregnancy prospectively may help to identify new early interventions that will increase the likelihood of success and help women make informed decisions regarding their pregnancies.

Interventions

  • OTHER Observational

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2015-07-31
Est. Completion 2019-08-31

What the Registry Record Tells You About NCT02626702

The ClinicalTrials.gov registry entry for NCT02626702 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.

NCT02626702 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02626702 about?

NCT02626702 is a clinical study titled "Immune Modulators and IVF". Exploring the immune mediators of early pregnancy prospectively may help to identify new early interventions that will increase the likelihood of success and help women make informed decisions regarding their pregnancies.

What is the current status of trial NCT02626702?

This trial is currently terminated. The enrollment target is 500 participants. The study started on 2015-07-31. Estimated completion is 2019-08-31.

What interventions are being tested in trial NCT02626702?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT02626702?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.